ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer

Gastric cancer (GC) remains a major public health problem. Ursolic acid (UA) is reported to be effective in inhibiting GC; however, its low solubility and poor biocompatibility have greatly hindered its clinical application. Herein, an innovative reactive oxygen species (ROS)-sensitive UA dimeric pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jiachi, Chen, Yuzhong, Liang, Wanqing, Li, Lei, Du, Jun, Pan, Chengwu, Zhang, Chensong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218932/
https://www.ncbi.nlm.nih.gov/pubmed/34142633
http://dx.doi.org/10.1080/10717544.2021.1937380

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218932/
https://www.ncbi.nlm.nih.gov/pubmed/34142633
http://dx.doi.org/10.1080/10717544.2021.1937380

Ejemplares similares